Table 3 Management of complicated cholelithiasis
Pediatric surgery, complicated cases (n = 11, 32% of pediatric surgery group) | Visceral surgery, complicated cases (n = 22, 42% of visceral surgery group) | p value | Test | |
|---|---|---|---|---|
Age at surgery [in years: median (range)] | 14 (7–17) | 23 (18–25) | ||
Index admission [n (%)] | < 0.001* | Fisher | ||
Internal/pediatric medical | 8 (73%) | 7 (32%) | ||
Surgical/pediatric surgical | 3 (27%) | 15 (68%) | ||
Time of symptoms [median (range)] | 58 days (4 days–41 months) | 11 days (1 day–31 months) | 0.119 | U test |
Complications [n (%), multiple answers possible] | ||||
Acute cholecystitis | 8 (73%) | 20 (91%) | 0.304 | Fisher |
Choledocholithiasis | 6 (55%) | 5 (23%) | 0.117 | Fisher |
Biliary pancreatitis | 8 (73%) | 3 (14%) | 0.001* | Fisher |
Time between diagnosis and surgery [median (range)] | 22 days (4 days–8 months) | 3 days (0 days–10 months) | 0.003* | U test |
Timing of surgery after diagnosis [n (%)] | < 0.001* | Fisher | ||
Surgery within day 0–4 | 1 (9%) | 17 (77%) | ||
Surgery within day 5–42 | 6 (55%) | 1 (5%) | ||
Surgery day > 42 | 4 (36%) | 4 (18%) | ||
C-reactive protein (CrP) at surgery [in mg/l: median (range)] | 1 (0–167) | 30 (0–221) | 0.004* | U test |
Number of hospital days after surgery [in days: median (range)] | 3 (3–8) | 3 (2–11) | 0.401 | U test |